Clinical Trial: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233655) titled 'A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis' on Nov. 13.

Brief Summary: This study is ongoing to explore the efficacy and safety of different strengths of SHR-3045 injection in moderate to severe active rheumatoid arthritis.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Active Rheumatoid Arthritis

Intervention: DRUG: SHR-3045 Injection

SHR-3045 injection.

DRUG: SHR-3045 Injection Placebo

SHR-3045 injection placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Published by HT Digital Content Services with ...